IBM, Hewlett Packard Enterprise and Eni SpA Agilysys have been highlighted in this Industry Outlook article.
24/7 Wall St. Insights International Business Machines Corp.
US computer giant IBM confirmed Monday it would close its research and development arm in China.
IBM (IBM) reportedly is closing its China research and development (R&D) department and moving those functions overseas.The Wall Street Journal said IBM executive Jack Hergenrother informed employees of the move in a virtual meeting Monday.
International Business Machines Corp (NYSE:IBM) has revealed it will be shuttering its research and development (R&D) operation in China, impacting more than 1,000 jobs. The tech company on Monday confirmed earlier media reports about the closure, stating to Reuters: "These changes will not impact our ability to support clients across the Greater China region.
Recently, Zacks.com users have been paying close attention to IBM (IBM). This makes it worthwhile to examine what the stock has in store.
IBM Corp. IBM is shutting down its research and development department in China in a move that will affect 1,000 jobs as technology companies continue moving out of the country, the Wall Street Journal reported Monday. IBM broke the news in a virtual meeting with employees in Asia, the WSJ reported. Employees told the WSJ some of the jobs will move to other locations such as Bangalore, India. An IBM China spokesperson did not comment, the WSJ said. IBM's stock fell 0.2% in premarket trading on Monday.
International Business Machines is moving the functions to other overseas facilities, The Wall Street Journal reported.
International Business Machines (NYSE: IBM) stock price was little changed on Monday after media reports noted that it was shutting down its R&D division in China, affecting over 1,000 jobs. Some of those jobs will move to Bangalore, India, where the country has a huge operation.
IBM will completely shutter its China R&D, with resulting layoffs affecting over 1,000 jobs, Chinese media outlet Yicai reported on Monday, citing a statement from the company.
IBM, an old company with a history of missed innovation, is now showing growth potential under new management. Software and GenAI business segments are driving high-single digit revenue growth and expanding margins for IBM by 100 bp. Free cash has been growing at one of the healthiest trajectories since 2020, on track to grow 7% in 2024.
IBM (IBM) reported earnings 30 days ago. What's next for the stock?